Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Reynolds

Showing results (101-110 of 1,272) with videos related to

Pageof 128
Sort By:
Current Opinion in Biotechnology|December 23, 2014
Genomic tools to assist breeding for drought tolerancePeter Langridge, Matthew P Reynolds
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Occupation and malignant melanoma of the skinD F Austin, P Reynolds
Journal of Neural Transmission|January 1, 1989
[3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophreniaC Czudek, G P Reynolds
Journal of Behavioral Medicine|February 1, 1988
Depression and cancer mortality and morbidity: prospective evidence from the Alameda County studyG A Kaplan, P Reynolds
Seminars in Diagnostic Pathology|May 24, 2020
Fine needle aspiration of mediastinal germ cell tumorsJordan P Reynolds, Shiguang Liu
European Journal of Pharmacology|January 5, 2000
Agonist-stimulated GTPgamma[35S] binding to 5-HT(1A) receptors in human post-mortem brainJ Elliott, G P Reynolds
Neuroscience Letters|May 4, 2001
Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophreniaS Nudmamud, G P Reynolds
Lancet (London, England)|December 14, 1985
Alzheimer-like brain monoamine deficits in adults with Down's syndromeG P Reynolds, H Godridge
British Journal of Clinical Pharmacology|January 1, 1980
Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's diseaseP Reiderer, G P Reynolds
Neuroscience Letters|August 17, 2005
An in vitro model of inflammatory neurodegeneration and its neuroprotectionKirsten Messmer, Gavin P Reynolds
Pageof 128

Showing results (101-110 of 1,272) with videos related to

Sort By:
Pageof 128
Current Opinion in Biotechnology|December 23, 2014
Genomic tools to assist breeding for drought tolerancePeter Langridge, Matthew P Reynolds
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1986
Occupation and malignant melanoma of the skinD F Austin, P Reynolds
Journal of Neural Transmission|January 1, 1989
[3H] GBR 12935 binding to the dopamine uptake site in post-mortem brain tissue in schizophreniaC Czudek, G P Reynolds
Journal of Behavioral Medicine|February 1, 1988
Depression and cancer mortality and morbidity: prospective evidence from the Alameda County studyG A Kaplan, P Reynolds
Seminars in Diagnostic Pathology|May 24, 2020
Fine needle aspiration of mediastinal germ cell tumorsJordan P Reynolds, Shiguang Liu
European Journal of Pharmacology|January 5, 2000
Agonist-stimulated GTPgamma[35S] binding to 5-HT(1A) receptors in human post-mortem brainJ Elliott, G P Reynolds
Neuroscience Letters|May 4, 2001
Increased density of glutamate/N-methyl-D-aspartate receptors in superior temporal cortex in schizophreniaS Nudmamud, G P Reynolds
Lancet (London, England)|December 14, 1985
Alzheimer-like brain monoamine deficits in adults with Down's syndromeG P Reynolds, H Godridge
British Journal of Clinical Pharmacology|January 1, 1980
Deprenyl is a selective inhibitor of brain MAO-B in the long-term treatment of Parkinsons's diseaseP Reiderer, G P Reynolds
Neuroscience Letters|August 17, 2005
An in vitro model of inflammatory neurodegeneration and its neuroprotectionKirsten Messmer, Gavin P Reynolds
Pageof 128